7,650.50

+36.50

+0.48%

52,104.00

+186.00

+0.36%

28,806.50

+272.50

+0.96%

Russell 2000 Futures

2,839.00

+17.70

+0.63%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,913.80

+14.90

+0.38%

78,559.56

+895.20

+1.15%

Crude Oil Dec 26

100.65

-3.47

-3.33%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqCM - BOATS Real Time Price USD

Firefly Neuroscience, Inc. (AIFF)

1.0000 -0.0300 (-2.91%)

At close: October 30 at 4:00:01 PM EDT

1.0000 0.0000 (0.00%)

Overnight: 8:02:46 PM EST

Loading Chart for AIFF

Chart Range Bar

Interval:

In partnership with ChartIQ

Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform

Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform

Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD

Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD

Firefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain Medicine

Firefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain Medicine

Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes

Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes

Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides

Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides

Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD

Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD

With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP Depository

With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP Depository

The Small Cap Showcase Highlights 8 Public Companies at Their Investor Conference Today

BC-Most Active Stocks

BC-Most Active Stocks

Firefly Confirms Public-Private Partnership with the Department of War

Firefly Confirms Public-Private Partnership with the Department of War

BC-Most Active Stocks

BC-Most Active Stocks

Mobilize your Website

View Site in Mobile | Classic

Share by: